Summary

A new Viewpoint published in JAMA from researchers at the University of Queensland, the University of Toronto and the University of California, San Francisco, is raising concern about a fast-growing but poorly understood trend: the use of injectable peptides marketed online for enhancement purposes, often beyond the reach of traditional drug regulation.

AI summaries can be wrong sometimes—always verify important details using the source article.